source
- Strategic CDMO partnerships shift from transactional to collaborative, emphasizing risk sharing and regulatory expertiseCDMO-sponsor relationships are moving away from simple outsourcing toward deeper strategic collaboration. Companies now look for partners who share risk, understand regulatory requirements, and pro…
- BMS lung drug meets low-dose endpoint in Phase 3 but high dose fails to improve lung functionBristol Myers Squibb reported that its LPA1 antagonist admilparant achieved the primary endpoint in a Phase 3 idiopathic pulmonary fibrosis study at the 60‑mg dose, showing a statistically signific…